Prevalence of peripheral arterial disease in subject with a moderate risk of Cardiovascular (CV) disease (CVD) in primary prevention - PANDORA

Study identifier:NIS-CEU-DUM-2006/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Prevalence of peripheral Arterial disease in subjects with a moderate CVD risk, with No overt vascular Diseases nOR diAbetes mellitus

Medical condition

Peripheral Arterial Disease (PAD)

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

9000

Study type

Observational

Age

45 Years +

Date

Study Start Date: 01 May 2007
Primary Completion Date: 01 Jul 2008
Study Completion Date: 01 Jul 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria